WoTS 2014

Visit the booth of Applikon Biotechnology at the largest industrial meeting point off the Netherlands

From the 30th of September until the 3rd of October, four worlds;
Automation, Laboratory, Motion & Drives and Electronics will be exhibiting in the Jaarbeurs Utrecht.
With the co-location of Macropak , European Dairy Industry Show and Industrial Processing the largest
industrial show of the Netherlands arises.
This offers more contact options to the visitors from industrial, healthcare and science background.

World of Technology and Science 
Date: Tuesday 30 September till 3 October 2014
Location: Jaarbeurs, Utrecht
Hall 7, Booth: 7B053

For direct registration, click here

More Information






Applikon Biotechnology and SecureCell sign Distribution agreement


New Advanced ProcessData Management Software Turns Process   Data into Information for Biopharmaceutical Process Development


DELFT (June22, 2014) – Applikon and SecureCell have signed an agreement for the worldwide marketing and sales of Advanced Process Information Management Software developed by SecureCell. The software allows the user to monitor and control bioprocesses and offers an extensive toolbox for analyzing process data cross platforms. Process information is generated based on data from different brands of bioreactors and a wide range of different cultivation volumes.

The software includes functionality for Design of Experiments, Reactor Planning, Media Preparation and Tracking, Parallel Processing, SCADA,Data Mining and Batch Reporting. The combination of the software with the broad range of Applikon Bioreactor Systems offers the user a unique system for validatable fast track development and basic research.

“The ever increasing amount of process data generated by more sensors in smaller parallel bioreactor systems needs advanced software to turn this data into useful information. With the SecureCell software we can offer a new dimension in data processing.Data management and data analysis is key for the future of R&D and process development in pharmaceutical industry. With this new software we are again leading the way in bioprocessing”said Erik Kakes, vice president of sales, Applikon Biotechnology.

“Applikon and SecureCell have a shared vision of the future of data management systems and we look forward to create solutions that integrate Applikon Bioreactors with our advanced software that has been developed over the past years in close cooperation with large pharmaceutical companies,” said Carlo Andretta, CEO of SecureCell.



newsflashIntroducing: micro-Matrix,

the next generation in microbioreactors

The unique micro-Matrix offers total control over 24 independent bioreactors in a simple microtiter plate footprint.Each of the 24 bioreactors on a plate offer independent controls like its larger stirred-tank relatives:

• pH (measurement and two-sided control)
• temperature (measurement and two-sided control, including plate-wide gradients)• dissolved oxygen control (measurement and two-sided control)
• individual liquid additions (including feeding profiles)
• up to 4 separate gas additions (individually controlled)


 MMAtrix 02 View06





Grand opening of Applikon Biotechnology China factory in Guangzhou.

Wednesday March 19th the Chinese factory of Applikon Biotechnology in Guangzhou has officially been opened. The presence of Chinese and Dutch goverment officials, highlighted the importance of this new milestone in the rapid development of our company. The factory is already operational since the end of 2013 and has assembled over 50 bioreactor systems. This extra capacity is needed to be able to cope with the increasing demand for Applikon bioreactors in China, the USA and in the rest of the world.
The opening ceremony was combined with a seminar titled:Innovations in bioreactor technology". International speakers presented new developments in bioreactor technology and showed the results of scientific cooperations between Applikon Biotechnology and several Universities.






King Willem-Alexander has opened our new headquarters


Opening klein 

On Wednesday December 4th the new headquarters of Applikon Biotechnology in Delft, the Netherlands has been officially opened by His Majesty King Willem-Alexander of the Netherlands. The grand opening was attended by (inter)national customers, business relations,(inter)national officials, scientific relations and the entire team of the Applikon Biotechnology in the Netherlands.

The new production facility has been operational for several months and the official opening was to officially mark this further step in the development and growth of Applikon Biotechnology. Company owners Arthur Oudshoorn, Jaap Oostra and Erik Kakes, and their dedicated team are proud and happy with these new premises which house the state-of-the-art warehouse and production facilities, R&D laboratory space and offices for approximately 100 employees.

In this new facility, Applikon Biotechnology  is now able to provide a complete range of bioreactor systems ranging from micro liter research volumes up to 15.000 liter production systems for pharmaceutical and biotechnological applications. 


<< Start < Prev 1 2 3 Next > End >>

Page 1 of 3
     Go to top   










© Copyright 2013 Applikon Biotechnology